About this trial
SHANTI-ICU compares the effectiveness of two evidence-based multicomponent ICU sleep promotion bundles on delirium and patient-reported sleep quality in critically ill adults.
Bundle A is a non-pharmacologic strategy. Bundle B includes all components of Bundle A plus pharmacist-led pharmacologic strategies. Sixteen intensive care units across eight hospitals implement one of the two bundles as a unit-level change to routine care, using a concurrent multiple-intervention stepped wedge randomized design.
The primary outcome is delirium incidence, measured using the Confusion Assessment Method for the ICU (CAM-ICU) as documented during routine clinical care. Secondary outcomes are delirium duration, ICU length of stay, nightly patient-reported sleep quality, and overall patient-reported ICU sleep quality.
Patients receive the assigned bundle as part of routine care. The study operates under an IRB-approved waiver of informed consent and waiver of HIPAA authorization; there is no individual enrollment procedure.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18 years or older
Present in participating ICU
Disqualifiers
Age less than 18 years
Present in ICU less than 1 night
Trial design
Parallel
Treatments tested in this trial
Nighttime noise & light reduction
BehavioralNighttime noise and light reduction to promote sleep. Prompted by a single-page bedside checklist.
Clustering patient-care interactions
BehavioralClustering patient-care interactions when possible, to reduce the number of times the patient is awakened during the night. Prompted by a single-page bedside checklist.
Non-pharmacologic sleep aids
BehavioralOffering non-pharmacologic sleep aids such as earplugs and eye masks. Prompted by a single-page bedside checklist.
Daytime light exposure
BehavioralPromote daytime wakefulness through light exposure. Prompted by a single-page bedside checklist.
Encourage out-of-bed activity
BehavioralPromote daytime wakefulness by encouraging out-of-bed activity. Prompted by a single-page bedside checklist.
Medication management to support nighttime sleep
Other interventionPharmacist conducts a medication review and makes recommendations related to deprescribing of medications known to disrupt sleep, optimization of medication administration timing, and selective use of sleep-promoting agents such as melatonin and dexmedetomidine when clinically appropriate. No specific medications will be given to all patients, only those recommended by the pharmacist to support sleep for that specific patient after careful review.
Treatment groups
Trial outcomes
Primary outcomes
Delirium incidence
Indicator that a patient screens positive on the Confusion Assessment Method for the ICU (CAM-ICU) at any point during their ICU stay. CAM-ICU is performed by ICU nursing staff as part of usual clinical care and abstracted from the health record.
Secondary outcomes
Delirium duration (delirium/coma-free days)
Number of days from ICU admission to day 7 on which the patient is alive, CAM-ICU negative, and not in coma. Days alive following ICU discharge are counted as delirium and coma free.
ICU sleep quality (Richards-Campbell Sleep Questionnaire)
Patient-reported rating of the previous night's sleep using the Richards-Campbell Sleep Questionnaire (RCSQ). The Richards-Campbell Sleep Questionnaire is a six-item visual analog scale along 100mm lines, the first five items relating to sleep quality and an optional sixth item relating to ICU noise. Each item is scored 0 to 100 and the first five of the items are averaged for a total score ranging from 0 to 100. Higher scores indicate better sleep quality. The Richards-Campbell Sleep Questionnaire is not completed for patients comatose overnight. Proxy completion by nursing staff is recorded and identified as such.
Overall ICU sleep quality (Sleep in the ICU Questionnaire)
One-time patient-reported rating of sleep quality across the entire ICU stay using the Sleep in the ICU Questionnaire (SICUQ), administered after ICU downgrade and before hospital discharge. The Sleep in the Intensive Care Unit Questionnaire uses items rated on a 1 to 10 numeric scale. For sleep quality items, higher scores indicate better sleep quality. For sleep disruption items, higher scores indicate more sleep disruption.
ICU Length of Stay
Length of stay in the ICU, calculated from the times of ICU arrival and ICU downgrade or death.
Other outcomes
Caregiver-reported sleep quality
Exploratory caregiver-reported measures using a modified Numeric Rating Scale for Sleep (NRS-Sleep). The Numeric Rating Scale for Sleep is a single-item rating of sleep quality on a scale of 0 to 10, with higher scores indicating better sleep quality.
Caregiver sleep experience
Exploratory caregiver-reported sleep experience using a modified Daily Use Caregiver Sleep Survey (DUCSS). The Daily Use Caregiver Sleep Survey mixes numerical responses with ordinal scales. Numerical items include questions such as asking for the time the participant went to bed and the number of hours of sleep. Other questions are scored on ordinal scales of 1-2, 1-3, and 1-5, with higher scores indicating lower sleep quality or higher sleep impairment.
Family satisfaction with ICU care
Exploratory family-reported satisfaction using a modified Family Satisfaction with Care in the Intensive Care Unit questionnaire (FS-ICU-24R). A family member rates their satisfaction with the patient's care in the ICU. Five-point Likert scale responses are transformed to a 0 to 100 percentage scale, with higher scores indicating greater satisfaction.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of California, San Diego
Lead sponsor
Patient-Centered Outcomes Research Institute
Collaborator
Johns Hopkins University
Collaborator
Massachusetts General Hospital
Collaborator
University of California, San Francisco
Collaborator
University of Utah
Collaborator
Vanderbilt University Medical Center
Collaborator
University of Puerto Rico
Collaborator
AdventHealth Orlando
Collaborator
Baylor University
Collaborator
This trial is not recruiting at the moment. You can still explore other options: